Early study checks how well new drug tablet works in healthy people
NCT ID NCT06717269
First seen Jun 24, 2026 · Last updated Jul 29, 2026 · Updated 3 times
Summary
This early-phase study is testing a drug called NX-5948 in 18 healthy adults to see how well a tablet form works compared to a capsule. It also looks at whether food or a common heartburn drug (esomeprazole) changes how the body absorbs NX-5948. The goal is to gather information for future studies, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- NX-5948
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Celerion
Phoenix, Arizona, 85283, United States
-
Celerion
Lincoln, Nebraska, 68502, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- First look: can a new drug candidate pass early safety tests in humans?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test
- Could a common drug shield the brain from Alzheimer's?